Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington’s Disease Mutation
Open Access
- 1 September 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (37) , 33791-33798
- https://doi.org/10.1074/jbc.m204861200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeatsNature, 2001
- The molecular biology of Huntington's diseasePsychological Medicine, 2001
- Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's diseaseProceedings of the National Academy of Sciences, 2000
- Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin [published erratum appears in Hum Mol Genet 1999 May;8(5):943]Human Molecular Genetics, 1999
- Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear InclusionsCell, 1998
- Ataxin-1 Nuclear Localization and AggregationCell, 1998
- Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregatesNature Genetics, 1998
- Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the MouseCell, 1997
- Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD MutationCell, 1997
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996